Closed · RFA-CI-10-003 · CFDA 93.521 · Discretionary

Patient Protection and Affordable Care Act (PPACA); Emerging Infections Program (EIP); Enhancing Epidemiology and Laboratory Capacity (U01)

Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.

up to $650K
Award range
Closed
Status
August 27, 2010
Close date
10
Expected awards

The verdict

Patient Protection and Affordable Care Act (PPACA); Emerging Infections Program (EIP); Enhancing Epidemiology and Laboratory Capacity (U01) is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered Up to $650,000 across 10 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 639 other opportunities from Centers for Disease Control and Prevention - ERA.

up to $650K
award range
Closed
application status
10
expected awards
93.521
CFDA program

Archived opportunity record

Patient Protection and Affordable Care Act is closed (last close August 27, 2010). Check the agency catalog for replacement NOFOs. Centers for Disease Control and Prevention - ERA still indexes 639 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed August 27, 2010

Posted Aug 17 Closes Aug 27

Est. Total Funding

$4,500,000

Expected Awards

10

Instrument

Cooperative Agreement

Description

The purpose of this EIP-ACA FOA is to support state and local health departments’ surveillance infrastructure through enhancement of the epidemiology and laboratory capacity of the existing EIP network. Over the past 15 years, the EIP network has proved to be a national resource for conducting active, population-based surveillance and special studies for invasive bacterial diseases, foodborne pathogens, healthcare associated infections (HAIs), influenza, and many other infectious diseases. The network has been instrumental in measuring the impact of the 7-valent pneumococcal conjugate vaccine, informing and evaluating treatment guidelines for Group B Streptococcus, estimating the burden of foodborne illness, documenting the emergence of community-associated methicillin-resistant Staphylococcus aureus, and monitoring the safety of the 2009 H1N1 vaccine as part of the influenza vaccine safety network (http://www.cdc.gov/ncpdcid/deiss/eip/publications.html). EIP activities and special studies frequently shift according to priorities for infectious disease emergency response and program areas. The flexibility of the network is ideal for implementing activities in response to rapidly changing scientific priorities. These investments in the basic infrastructure support multiple activities at each site and are critical for a comprehensive, efficient, and coordinated approach to general program management from which all activities benefit. EIP sites may conduct up to 65 different surveillance and research activities related to infectious diseases during the course of a year. These activities require investments in personnel time to implement or modify, including building collaborative relationships with local hospitals, laboratories, and healthcare providers; submitting applications to multiple institutional review boards for dozens of studies; hiring, supervising and training staff; facilitating information exchange between CDC, local epidemiologists and laboratories; and actively participating in numerous conference calls, conferences, and meetings with CDC investigators. Given the significant activities of EIP sites, this FOA provides an opportunity to enhance support for the basic infrastructure of the EIP network.

Catch-all / unrestricted eligibility mark · RFA-CI-10-003

Grants.gov marks Patient Protection and Affordable Care Act with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Centers for Disease Control and Prevention - ERA book (299 peers, 47% of 640).

Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Centers for Disease Control and Prevention Procurement and Grants Office TIMS Phone 770-488-2700

What to do next

Patient Protection and Affordable Care Act is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 93.521 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants